{"entity":{"type":"insider","cik":"0001353502","url":"/insider/0001353502","json_url":"/insider/0001353502.json","name":"GCE Holdings LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":9,"first":"2007-08-22","last":"2012-04-04","span_basis":"filed_date"},"name_variants":[{"name":"GCE Holdings LLC","source":"filing","n_filings":9,"first_seen":"2007-08-22","last_seen":"2012-04-04"}],"transactions":[{"id":2834591,"accession":"0001104659-12-023882","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-023882","line_url":"/filing/0001104659-12-023882#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":"0001353502","owner_name":"GCE Holdings LLC","owner_display_name":"GCE Holdings LLC","owner_url":"/insider/0001353502","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1168.0,"shares_display":"1,168","price_per_share":3.52,"price_display":"3.52","price_state":"stated","total_value":4111.36,"total_display":"4,111.36","total_whole":"4,111","shares_owned_after":32511464.0,"shares_owned_after_display":"32,511,464","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-04-02","filed_date":"2012-04-04","scope":"insider"},{"id":3409377,"accession":"0001104659-12-023202","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-12-023202","line_url":"/filing/0001104659-12-023202#line-2","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":"0001353502","owner_name":"GCE Holdings LLC","owner_display_name":"GCE Holdings LLC","owner_url":"/insider/0001353502","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14155.0,"shares_display":"14,155","price_per_share":3.51,"price_display":"3.51","price_state":"stated","total_value":49684.05,"total_display":"49,684.05","total_whole":"49,684","shares_owned_after":32512632.0,"shares_owned_after_display":"32,512,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-30","filed_date":"2012-04-02","scope":"insider"},{"id":3409375,"accession":"0001104659-12-023202","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-023202","line_url":"/filing/0001104659-12-023202#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":"0001353502","owner_name":"GCE Holdings LLC","owner_display_name":"GCE Holdings LLC","owner_url":"/insider/0001353502","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7376.0,"shares_display":"7,376","price_per_share":3.58,"price_display":"3.58","price_state":"stated","total_value":26406.08,"total_display":"26,406.08","total_whole":"26,406","shares_owned_after":32526787.0,"shares_owned_after_display":"32,526,787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-29","filed_date":"2012-04-02","scope":"insider"},{"id":2834580,"accession":"0001104659-12-022419","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-12-022419","line_url":"/filing/0001104659-12-022419#line-2","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":"0001353502","owner_name":"GCE Holdings LLC","owner_display_name":"GCE Holdings LLC","owner_url":"/insider/0001353502","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6001.0,"shares_display":"6,001","price_per_share":3.67,"price_display":"3.67","price_state":"stated","total_value":22023.67,"total_display":"22,023.67","total_whole":"22,024","shares_owned_after":32534163.0,"shares_owned_after_display":"32,534,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-28","filed_date":"2012-03-29","scope":"insider"},{"id":2834575,"accession":"0001104659-12-022419","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-022419","line_url":"/filing/0001104659-12-022419#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":"0001353502","owner_name":"GCE Holdings LLC","owner_display_name":"GCE Holdings LLC","owner_url":"/insider/0001353502","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25872.0,"shares_display":"25,872","price_per_share":3.78,"price_display":"3.78","price_state":"stated","total_value":97796.16,"total_display":"97,796.16","total_whole":"97,796","shares_owned_after":32540164.0,"shares_owned_after_display":"32,540,164","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-27","filed_date":"2012-03-29","scope":"insider"},{"id":3388253,"accession":"0001104659-12-021442","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-12-021442","line_url":"/filing/0001104659-12-021442#line-2","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":"0001353502","owner_name":"GCE Holdings LLC","owner_display_name":"GCE Holdings LLC","owner_url":"/insider/0001353502","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":3.82,"price_display":"3.82","price_state":"stated","total_value":76400.0,"total_display":"76,400.00","total_whole":"76,400","shares_owned_after":32566036.0,"shares_owned_after_display":"32,566,036","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-26","filed_date":"2012-03-27","scope":"insider"},{"id":3388252,"accession":"0001104659-12-021442","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-021442","line_url":"/filing/0001104659-12-021442#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":"0001353502","owner_name":"GCE Holdings LLC","owner_display_name":"GCE Holdings LLC","owner_url":"/insider/0001353502","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12565.0,"shares_display":"12,565","price_per_share":3.72,"price_display":"3.72","price_state":"stated","total_value":46741.8,"total_display":"46,741.80","total_whole":"46,742","shares_owned_after":32586036.0,"shares_owned_after_display":"32,586,036","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-23","filed_date":"2012-03-27","scope":"insider"},{"id":3430571,"accession":"0001104659-12-020778","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-12-020778","line_url":"/filing/0001104659-12-020778#line-2","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":"0001353502","owner_name":"GCE Holdings LLC","owner_display_name":"GCE Holdings LLC","owner_url":"/insider/0001353502","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7118.0,"shares_display":"7,118","price_per_share":3.91,"price_display":"3.91","price_state":"stated","total_value":27831.38,"total_display":"27,831.38","total_whole":"27,831","shares_owned_after":32598601.0,"shares_owned_after_display":"32,598,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-22","filed_date":"2012-03-23","scope":"insider"},{"id":3430570,"accession":"0001104659-12-020778","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-020778","line_url":"/filing/0001104659-12-020778#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":"0001353502","owner_name":"GCE Holdings LLC","owner_display_name":"GCE Holdings LLC","owner_url":"/insider/0001353502","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17145.0,"shares_display":"17,145","price_per_share":4.04,"price_display":"4.04","price_state":"stated","total_value":69265.8,"total_display":"69,265.80","total_whole":"69,266","shares_owned_after":32605719.0,"shares_owned_after_display":"32,605,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-21","filed_date":"2012-03-23","scope":"insider"},{"id":2777306,"accession":"0001104659-12-019683","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-12-019683","line_url":"/filing/0001104659-12-019683#line-2","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":"0001353502","owner_name":"GCE Holdings LLC","owner_display_name":"GCE Holdings LLC","owner_url":"/insider/0001353502","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80400.0,"shares_display":"80,400","price_per_share":4.12,"price_display":"4.12","price_state":"stated","total_value":331248.0,"total_display":"331,248.00","total_whole":"331,248","shares_owned_after":32622864.0,"shares_owned_after_display":"32,622,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-20","filed_date":"2012-03-21","scope":"insider"},{"id":2777299,"accession":"0001104659-12-019683","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-019683","line_url":"/filing/0001104659-12-019683#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":"0001353502","owner_name":"GCE Holdings LLC","owner_display_name":"GCE Holdings LLC","owner_url":"/insider/0001353502","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45900.0,"shares_display":"45,900","price_per_share":3.83,"price_display":"3.83","price_state":"stated","total_value":175797.0,"total_display":"175,797.00","total_whole":"175,797","shares_owned_after":32703264.0,"shares_owned_after_display":"32,703,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-19","filed_date":"2012-03-21","scope":"insider"},{"id":2134644,"accession":"0001104659-12-019185","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-12-019185","line_url":"/filing/0001104659-12-019185#line-2","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":"0001353502","owner_name":"GCE Holdings LLC","owner_display_name":"GCE Holdings LLC","owner_url":"/insider/0001353502","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11200.0,"shares_display":"11,200","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":39200.0,"total_display":"39,200.00","total_whole":"39,200","shares_owned_after":32749164.0,"shares_owned_after_display":"32,749,164","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-16","filed_date":"2012-03-19","scope":"insider"},{"id":2134580,"accession":"0001104659-12-019185","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-019185","line_url":"/filing/0001104659-12-019185#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":"0001353502","owner_name":"GCE Holdings LLC","owner_display_name":"GCE Holdings LLC","owner_url":"/insider/0001353502","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":3.41,"price_display":"3.41","price_state":"stated","total_value":10230.0,"total_display":"10,230.00","total_whole":"10,230","shares_owned_after":32760364.0,"shares_owned_after_display":"32,760,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-15","filed_date":"2012-03-19","scope":"insider"},{"id":3162123,"accession":"0001104659-12-018534","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-018534","line_url":"/filing/0001104659-12-018534#line-1","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":"0001353502","owner_name":"GCE Holdings LLC","owner_display_name":"GCE Holdings LLC","owner_url":"/insider/0001353502","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15111.0,"shares_display":"15,111","price_per_share":3.39,"price_display":"3.39","price_state":"stated","total_value":51226.29,"total_display":"51,226.29","total_whole":"51,226","shares_owned_after":32763364.0,"shares_owned_after_display":"32,763,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-13","filed_date":"2012-03-15","scope":"insider"},{"id":7468268,"accession":"0001179110-07-017203","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001179110-07-017203","line_url":"/filing/0001179110-07-017203#line-7","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR.OB","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":"0001353502","owner_name":"GCE Holdings LLC","owner_display_name":"GCE Holdings LLC","owner_url":"/insider/0001353502","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":38125924.0,"shares_display":"38,125,924","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":327784758.0,"shares_owned_after_display":"327,784,758","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-20","filed_date":"2007-08-22","scope":"insider"},{"id":7468266,"accession":"0001179110-07-017203","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-07-017203","line_url":"/filing/0001179110-07-017203#line-6","is_derivative":false,"issuer_cik":"0000786947","issuer_name":"ACURA PHARMACEUTICALS, INC","issuer_ticker":"ACUR.OB","issuer_name_source":null,"issuer_url":"/issuer/0000786947","owner_cik":"0001353502","owner_name":"GCE Holdings LLC","owner_display_name":"GCE Holdings LLC","owner_url":"/insider/0001353502","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33333332.0,"shares_display":"33,333,332","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":289658834.0,"shares_owned_after_display":"289,658,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-20","filed_date":"2007-08-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000786947","name":"ACURA PHARMACEUTICALS, INC","url":"/issuer/0000786947","role":"Ten percent owner","n_filings":9,"first_seen":"2007-08-22","last_seen":"2012-04-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001353502","retrieved_at":"2026-08-22T11:25:47+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}